Feasibility and Reliability of Ultrasound in Acute Burns.

Sponsor
Universiteit Antwerpen (Other)
Overall Status
Completed
CT.gov ID
NCT04852133
Collaborator
Research Foundation Flanders (Other)
20
2
11.1
10
0.9

Study Details

Study Description

Brief Summary

This trial investigates the feasibility and reliability of different ultrasound protocols to determine quadriceps muscle architecture in acutely admitted burn patients. The results of this trial will provide more clarity as to whether ultrasound can be used as a bedside tool to monitor muscle wasting.

Condition or Disease Intervention/Treatment Phase
  • Other: Burn subjects

Detailed Description

BACKGROUND Despite the ubiquity of muscle wasting following burns, practical and accurate tools to measure the degree of muscle wasting are lacking in burn care. Ultrasound has been used for this purpose in the critically-ill population and has shown to be valid and reliable. Whether this can be extrapolated to the burn population, however, remains unclear. Open wounds, fluid status, and uncertainty regarding which protocol to use are amongst factors that complicate the use of ultrasound during the acute phase of burns.

AIM This study examines the reliability and feasibility of ultrasound measures in the acute burn setting comparing different techniques and locations of application.

METHODS Burned adults were assessed at admission in two Belgian burn centers by two trained assessors using B-mode ultrasound with a linear transducer. Ultrasound-derived variables included quadriceps muscle layer thickness (QMLT) and rectus femoris cross-sectional area (RF-CSA) on both thighs. Both maximum and minimum compression techniques were used for QMLT, while RF-CSA was determined by minimum compression only. QMLT was measured at a proximal and distal location on the thigh, and RF-CSA was measured at the most proximal location possible where the entire muscle belly still remained visible.

Study Design

Study Type:
Observational
Actual Enrollment :
20 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Feasibility and Reliability of Ultrasound Assessment of Muscle Architecture in Acute Burns.
Actual Study Start Date :
May 4, 2020
Actual Primary Completion Date :
Apr 6, 2021
Actual Study Completion Date :
Apr 6, 2021

Arms and Interventions

Arm Intervention/Treatment
Burn subjects

exposure to burn injury

Other: Burn subjects
see eligibility criteria

Non-burned control

no exposure to burn injury

Outcome Measures

Primary Outcome Measures

  1. Reliability [<72 hours of admission]

    Interrater reliability of QMLT and RF-CSA assessed by intraclass correlation

Secondary Outcome Measures

  1. Feasibility of measurements [<72 hours of admission]

    Feasibility of different techniques and locations of measurements, assessed by number of realised vs attempted measurements

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Burn subjects:
Inclusion Criteria:
  • ≥10 - ≤80 %TBSA

  • Burn depth: 2nd deep / 3rd degree

Exclusion Criteria:
  • Electrical burn (except flash burns)

  • Associated injury: fracture lower limb

  • Diabetes Mellitus type 1

  • Central / peripheral neurological/neuromuscular disorders (interfering with exercise)

  • Cognitive / psychological disorders (interfering with cooperation)

  • Cardiopulmonary disease (interfering with exercise safety)

  • Pregnancy

  • Palliative care

Healthy subjects:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ziekenhuis Netwerk Antwerpen Stuivenberg Antwerp Belgium 2060
2 Militaire Hospitaal Koningin Astrid, Neder-Over-Heembeek Brussels Belgium 1120

Sponsors and Collaborators

  • Universiteit Antwerpen
  • Research Foundation Flanders

Investigators

  • Principal Investigator: Ulrike Van Daele, PhD, University of Antwerp, Faculty of Medicine and Health Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ulrike Van Daele, Full Professor, Universiteit Antwerpen
ClinicalTrials.gov Identifier:
NCT04852133
Other Study ID Numbers:
  • 11B8619N[US]
First Posted:
Apr 21, 2021
Last Update Posted:
Oct 19, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ulrike Van Daele, Full Professor, Universiteit Antwerpen
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 19, 2021